“Rivaroxaban Versus Warfarin for Prevention of Thromboembolism in Bangladeshi Patients With Non-Valvular Atrial Fibrillation”. University Heart Journal, vol. 16, no. 2, Oct. 2020, pp. 99-105, https://doi.org/10.3329/uhj.v16i2.49666.